2022-23 Annual report
2022-23 Executive team
April 1, 2022 – March 31, 2023
Dr. Craig Earle
Chief Executive Officer
David Lynch
Vice President, Finance and Corporate Services
Erika Nicholson
Vice President, Cancer Control
Rami Rahal
Vice President, Cancer Systems, Performance and Innovation
Andrea Reed
Vice President, Strategic Partnerships